INTRODUCTION
============

The innate immune system is critical for the host not only to control microbial infection at the front line of immune defense, but also to maintain the mutualistic relationship with the resident microbiota community, which is of great importance for supporting and sustaining health. An essential aspect of the *Drosophila melanogaster* immune response, which is equivalent to innate immunity in mammals, is the spatially and temporally regulated expression of a battery of antimicrobial peptides (AMPs) ([@B1; @B2; @B3; @B4; @B5]). The AMPs have different spectra of activity, targeting different classes of pathogenic microorganisms ([@B1; @B2; @B3]). Diptericin (Dpt), Drosocin (Dro) and Attacin (Att) act against Gram-negative bacteria. Defensin (Def) is active against Gram-positive bacteria, whereas Drosomycin (Drs) and Metchnikowin (Mtk) are antifungal agents. Cecropin A1 (CecA1) has a broad antibacterial spectrum against both bacteria and fungi ([@B6],[@B7]). Each AMP works in concert with others to take effect with an integrated and proper antimicrobial scope. Because of the distinct antibacterial spectrum of each AMP, the tight regulation of extent and duration of individual AMP expression contributes greatly to the overall effect on the resistance to pathogens and the maintenance of the resident microbiota ([@B8],[@B9]). Therefore, it is important to elucidate the differentially regulated gene expression of AMPs with distinct kinetics and antimicrobial spectra at multiple levels. Such an understanding would lead to the revelation of its crucial role in the orchestration of effective and efficient antimicrobial spectra by precise expression control of distinct AMPs in properly regulated host immune responses.

Although AMPs are constitutively synthesized in specific tissues at a basal level ([@B3]), a characteristic aspect of AMP synthesis in *D. melanogaster* is the transient expression of a battery of antimicrobial peptides upon immune response, which is critical for protection against many microbial pathogens ([@B1; @B2; @B3],[@B10],[@B11]). Prior to infection, most AMP mRNA levels are very low, but transcripts accumulate rapidly after infection ([@B3],[@B5],[@B12]). From then on, AMP mRNA levels decrease ([@B3],[@B12]). Certainly, the transient expression of AMP genes is tightly regulated so that insects can response to antigen quickly to resist the predation of rapidly dividing pathogenic microorganisms, and then withdraw highly active AMPs successively to avoid prolonged inhibition of mutualistic microbiota in the host ([@B8; @B9; @B10; @B11]). This delicate regulation depends upon the interplay among elements that control gene expression at multiple levels such as transcription, mRNA stability and translation ([@B13]).

Undoubtedly, transcriptional control at κB-like sites bound by Rel family proteins ([@B14; @B15; @B16; @B17; @B18]) is a determinant of the distinct spectra and of the stereotypical kinetics of AMP gene expression activated by different microbes through Toll and IMD pathways ([@B3],[@B5],[@B11],[@B19]). In fact, in addition to transcription, posttranscriptional events, particularly the stability of specific mRNA, are also important determinants of the extent and duration of gene expression ([@B12],[@B20; @B21; @B22; @B23]). After analysis of sequence motifs in *Drosophila* AMPs, it was observed that the mRNA 3′-UTR of quite a few AMPs contain AU-rich sequences similar to the adenylate and uridylate rich element (AU-rich element, ARE). This is a highly conserved posttranscriptional regulatory element found throughout evolution from yeasts and insects to mammals ([@B24; @B25; @B26]). In mammalian cells, ARE controls mRNA stability via interactions with specific RNA binding proteins: some ARE-binding proteins (AUBPs) target the transcript for degradation, such as tristetraprolin (TTP), whereas others, such as HuR, mediate transcript stabilization ([@B20],[@B26; @B27; @B28; @B29]). In addition, it has been implied that AREs can exert either a stabilizing or destabilizing effect on mRNA depending upon the p38 mitogen-activated protein kinase (p38MAPK) activity within the mammalian cells ([@B30],[@B31]). In general, the ARE sequences specifically bound by AUBPs include a central AU~3-5~A core with a UU contributed from the AU~3-5~A on either side and are always found in the 3′-UTR of a variety of immediate response genes, including those encoding cytokines, inflammatory mediators and other such molecules ([@B25],[@B26],[@B28],[@B32],[@B33]). In light of the presence of ARE motifs in the 3′-UTR of AMP mRNA, one may speculate that the transient expression of AMPs may be under tight regulation at the posttranscriptional level, particularly with regard to transcript stability control. Thus, it is important to explore the fundamental aspects of and relevant approaches to mRNA stability regulation that control AMP expression differentially, and that could ultimately translate the distinct expression kinetics of each AMP gene into a dynamic and delicately orchestrated antimicrobial spectrum combining each AMP's intensity, duration and specific activity.

In this study, posttranscriptional analyses of gene expression of representative AMPs including *CecA1* and *Dpt*, which have similar but not identical ARE sequences located in the 3′-UTR, were performed to elucidate the differential regulation of mRNA stability in AMP gene expression and the crucial role of p38MAPK in stabilizing ARE-bearing mRNAs by inhibiting Tis11-mediated degradation in LPS induced AMP expression in *Drosophila* macrophage-like S2\* cells.

MATERIALS AND METHODS
=====================

Reagents
--------

*Escherichia coli* Lipopolysaccharides (LPS) (62326), SB203580 and 20-hydroxy-ecdysone (H5142) were obtained from Sigma-Aldrich. Actinomycin D (Act.D) was purchased from Ameresco, His-tag antibody from Abmart. The gene-specific primers were synthesized by Invitrogen China.

Cell culture
------------

*Drosophila* Schneider (S2\*) cells (kindly provided by Dr Ge Baoxue) were cultured in 1×Schneider's *Drosophila* medium (Invitrogen) supplemented with 10% FBS (Invitrogen), 50 U/ml penicillin and 50 ng/ml streptomycin at 25°C ([@B34]). For the treatment with LPS in which peptidoglycan (PGN) was the immune activator with the ability to activate the IMD pathway ([@B35],[@B36]), S2\* cells were incubated with 1 µM 20-hydroxy-ecdysone to induce differentiation for at least 24 h prior to stimulation with 10 µg/ml LPS. For p38MAPK inhibition, cells were incubated with 10 μM SB203580 or with vehicle (1% dimethyl sulfoxide, DMSO) for 30 min prior to stimulation.

Plasmid constructs
------------------

The *firefly luciferase* (*Fluc*) gene and polyA signal of *SV40* from pGL-3 Basic (Promega) was sub-cloned into pAc5.1-Flag-V5-His C vector with KpnІ and SalІ to construct pAC-Fluc plasmid. Using the S2\* cells cDNA as templates, the 3′-UTR of *Dpt* (147 bp), heat shock protein 70 (*HSP70*) (234 bp) and ribosomal protein 49 (*rp49*) (162 bp), and fragments of I (full length of *CecA1* 3′-UTR, 97 bp), II (70 bp), III (55 bp), IV (42 bp), V (19 bp) of *CecA1* 3′-UTR were synthesized by PCR with specific primers ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkp693/DC1)). The 3′-UTR of *TNF-α* was PCR amplified using THP1 cells cDNA as templates. Excised with XbaІ or NheІ and purified with a Gel Extract kit (Omega). DNA fragments were ligated into the unique XbaІ site of the pAC-Fluc, located downstream of the *Fluc* coding sequence. The *renilla luciferase* (*Rluc*) gene from pRL-SV40 (Promega) was ligated into NheІ-XbaІ sites of pAC-Fluc to replaced *Fluc* for pAC-Rluc plasmid construction. The coding region of *Drosophila Tis11* was PCR amplified and sub-cloned into pAc5.1-Flag-V5-His C vector with the KpnІ and NotІ sites residing downstream of *actin5C* promoter and upstream of 6×His tag to make pAC-Tis11-His. The coding region of human *TTP* from pCDNA3.0-myc-TTP plasmid was sub-cloned into pAc5.1-Flag-V5-His C plasmid with HindШ and NotІ to construct pAC-TTP plasmid. All DNA constructs were verified by DNA sequencing (Invitrogen, Shanghai, China).

RNA isolation and analysis of gene expression
---------------------------------------------

Total RNA was isolated from S2\* cells using Trizol reagent (Invitrogen) and treated with DNase (Promega). Total RNA (1 µg) was used together with MMLV reverse transcriptase (Promega) and oligo (dT)~18~ primer to synthesize first strand cDNA, which was used as a template for quantitative real time RT--PCR (qRT--PCR) with gene-specific primer pairs ([Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkp693/DC1)) and SYBR Green PCR master mix (Toyobo) on an ABI PRISM 7900 Fast Real Time PCR System (Applied Biosystems). The expression level of *CecA1* or *Dpt* was normalized to *rp49* and *Fluc* was normalized to *Rluc* in each sample in order to quantify the relative levels of a given mRNA according to the Δ*C*~t~ analysis. For absolute quantitative real time RT--PCR, the DNA standard samples for AMPs and *rp49* were made by PCR amplification and quantified using a spectrophotometer (Beckman DU800). Absolute quantitative real time RT--PCR was performed using serially diluted standard samples as templates to make a standard amplification curve.

Act.D chase studies for mRNA stability measurement
--------------------------------------------------

For mRNA stability assays, S2\* cells were incubated with 10 µg/ml Act.D to inhibit transcription. At the indicated time points after the addition of Act.D, cells were harvested and total RNA was extracted. The expression levels of *CecA1*, *Dpt* and *Fluc* at each time point were measured by qRT--PCR as described earlier and normalized to the according *rp49* levels. The remaining mRNA was determined by comparison with the expression level of the relevant gene at the zero time point (designated 100%) when Act.D was added.

Cell transfection and luciferase reporter assay
-----------------------------------------------

S2\* cells were seeded at a density of 1 × 10^6^ cells/ml in 6-well plates. The next day, 0.5 µg Fluc reporter plasmids containing the indicated fragment from 3′-UTR of various genes and 0.5 µg Rluc reporter plasmids (pAC-Rluc) were co-transfected into cells using the calcium phosphate precipitation method (Invitrogen). Three days after transfection, cells were harvested and luciferase activities were measured according to the recommended procedures for the dual luciferase assay system (Promega) on a PerkinElmer Lumat LB 9507 luminometer. The Fluc activity was normalized to the activity of Rluc.

RNA interference
----------------

The primer sequences ([Supplementary Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkp693/DC1)) used to generate templates for synthesizing double-strand RNA (dsRNA) of *Tis11* and *EGFP* included a 5′ T7 RNA polymerase-binding site. For *Tis11* dsRNA template amplification, S2\* cells cDNA was used as template in RT--PCR, while pEGFP-C1 vector (Clontech) was used as template to amplify *EGFP* dsRNA template. The purified PCR products were used as templates to produce dsRNA by using a MEGAscript RNAi kit (Ambion). A 15 µg dsRNA was transfected into 2 ml S2\* cells (1 × 10^6^/ml in 6-well plate) using a calcium phosphate precipitation method (see above) with or without reporter plasmid.

Immunoprecipitation and complex analysis
----------------------------------------

S2\* cells were seeded in 6-well plates and transiently transfected with pAC-Tis11-His plasmid or blank control pAc5.1-Flag-V5-His C vector using a calcium phosphate precipitation method (see above). Three days later, the S2\* cells were stimulated with LPS for 3 h, inducing AMP mRNA to high levels. The cells were then lysed for 10 min on ice in RNA immunoprecipitation (RIP) buffer \[50 mM Tris (pH 7.4), 150 mM NaCl, 0.5% Nonidet P-40, 1 mM DTT, 100 U/ml RNase inhibitor (Promega), 2.5% proteinase inhibitor cocktails (Sigma), 2 mM vanadyl ribonucleoside complexes (NEB)\]. The cell lysate was centrifuged at 14 000 *g* for 10 min at 4°C and the supernatant of the cytoplasmic lysate was collected for RNA IP assays. Precleared with protein-A Sepharose beads (Amersham), lysates were incubated with 1 µg mouse His-tag antibody to immunoprecipitate Tis11-His fusion protein and rotated for 12 h at 4°C. Five percent (v/v) protein-A beads were added for another 4 h and were washed several times with RIP buffer for IP complex isolation. RNA was extracted from the IP complex and the presence of specific mRNAs in the IP complex was determined by RT--PCR with gene-specific primers. A low-level signal of housekeeping transcript *rp49* was detectable in all samples and served to monitor the quality and evenness of sample input.

RESULTS
=======

Transiently expressed AMP genes have distinct kinetics and show substantial differences in mRNA stability
---------------------------------------------------------------------------------------------------------

Posttranscriptional regulatory studies of the expression of genes encoding AMPs with distinct antimicrobial spectra were performed on the widely used *Drosophila* cellular model---macrophage-like S2 cells which can express a spectrum of AMPs in response to immune stimulants and can thus allow more precise manipulation.

To determine the similarity and dissimilarity in expression profiles of AMP genes, an absolute quantitative real-time RT--PCR method was used to compare the mRNA expression levels of different AMPs. As shown in [Figure 1](#F1){ref-type="fig"}A, whether or not S2\* cells were stimulated with LPS for 2 and 4 h, the mRNA of *CecA1* was the most abundant transcript among the detected AMPs including *Dpt*, *Def*, *Dro*, *AttB*, *Mtk* and *Drs*. The mRNA levels of the other AMPs were moderate, while *Dpt* mRNA displayed a relatively high level. To investigate whether the gene expression of the *CecA1* and other AMPs were differentially regulated, we first examined the expression kinetics of *CecA1* and *Dpt* by comparing their mRNA time course after immune stimulation. [Figure 1](#F1){ref-type="fig"}B and C show the *CecA1* and *Dpt* mRNA expression profiles from 0 to 10 h in S2\* cells stimulated with LPS. Both had similar fold changes of mRNA levels when stimulated and showed comparable transient expression characteristics. However, it was observed that the *CecA1* mRNA decreased rapidly to almost basal level within 4--6 h, whereas the *Dpt* mRNA remained at a high level for up to 10 h. Obviously, the two AMP mRNAs had different expression kinetics as a result of differential regulation. Figure 1.The gene expression profiles and mRNA stability of different AMPs. (**A**) Absolute quantitative real-time RT--PCR analysis of the amount of AMPs and *rp49* transcript in S2\*cells treated with 10 µg/ml LPS for 0, 2 and 4 h, with the use of an amplification standard curve for each gene. Taking the amount of *rp49* as 1, the expression level of each AMP was calculated. (**B** and **C**) The qRT--PCR analysis of *CecA1* (B) and *Dpt* (C) mRNA in S2\* cells treated with 10 µg/ml LPS for the time indicated. The fold changes of *CecA1* and *Dpt* mRNA were detected at each time point, taking the mRNA level at 0 h as 1. (**D** and **E**) S2\* cells were stimulated with LPS for 2 h (D) or not stimulated (E), and further incubated with 10 µg/ml Act.D for the time indicated. The qRT--PCR was performed to detect *CecA1* and *Dpt* mRNA remaining at each time point, taking the mRNA level at the time of Act.D added as 1. Values represent the mean ± SD (*n* = 3 independent experiments), \**P*\<0.05; \*\**P*\<0.01 for *CecA1* versus *Dpt* at each time point.

To determine whether mRNA stability was involved in the difference between the two AMP expression profiles, Act.D chase studies were used to eliminate effects of transcription on AMP expression and to determine the rate of mRNA decay. As shown in [Figure 1](#F1){ref-type="fig"}D, the decay rate of *CecA1* mRNA (*t*~1/2~ = 1.73 h) was much quicker than that of *Dpt* mRNA which remained stable (*t*~1/2~ \> 4 h) throughout the course of the 4-h observation with LPS treatment ([Figure 1](#F1){ref-type="fig"}D). The results clearly show that *CecA1* mRNA is much more unstable than *Dpt* mRNA, indicating that mRNA stability is an important determinant in the differences in extent and duration of AMP gene expression after immune stimulation.

To test whether the stability of AMP mRNA was influenced by immune stimulation, *CecA1* and *Dpt* mRNA decay rates were also detected in S2\* cells at basal level without LPS treatment ([Figure 1](#F1){ref-type="fig"}E). Nevertheless, the decay rate of *CecA1* mRNA was almost the same as the stimulated one with a half-life of 1.8 h, while *Dpt* mRNA was significantly stable during the 4-h observation period. Thus, the mRNA stability of each AMP was not altered whether or not S2\* cells were stimulated with LPS ([Figure 1](#F1){ref-type="fig"}, compare D and E). These results suggest that the decay rates of *CecA1* and *Dpt* mRNAs were well maintained in a constitutive manner and that the mRNA stability of both AMPs were under posttranscriptional regulatory control which could sustain a steady decay rate for the transcript in response to LPS stimulation.

In contrast to *Dpt* 3′-UTR, the *CecA1* 3′-UTR is sufficient to confer instability on a reporter mRNA
------------------------------------------------------------------------------------------------------

As for the posttranscriptional control of mRNA stability, the AU-rich sequences can be found in the 3′-UTR of several AMP mRNAs. Both the *CecA1* 3′-UTR and *Dpt* 3′-UTR contain AU-rich sequences which may act as *cis*-acting elements in posttranscriptional regulation. Therefore, reporter gene constructs of the luciferase reporter assay system were created by inserting DNA encoding the 3′-UTR of *CecA1* or *Dpt* downstream of the *Fluc* gene which was driven by *actin5C* promoter ([Figure 2](#F2){ref-type="fig"}A). To validate the reliability of this method, we used the 3′-UTR of *rp49*, a housekeeping gene, as a stable control and *HSP 70* 3′-UTR as an unstable control ([@B37]) for the reporter system. Insertion of the *HSP70* 3′-UTR resulted in great reduction of Fluc at protein level and mRNA level with up to 80% expression inhibited, whereas insertion of *rp49* 3′-UTR had a little but not significant effect on the expression as compared with pAC-Fluc control vector without 3′-UTR sequence inserted ([Figure 2](#F2){ref-type="fig"}B and C). Subsequently, the regulatory roles of AMPs 3′-UTR were analyzed using this effective and efficient reporter system for posttranscriptional studies. Figure 2.*CecA1* and *Dpt* 3′-UTR influenced reporter expression differently. (**A**) Diagram of reporter gene constructs pAC-Fluc-3′-UTR. The 3′-UTR of *CecA1*, *Dpt*, *rp49* and *HSP70* (sequences shown in [Supplementary Table 4](http://nar.oxfordjournals.org/cgi/content/full/gkp693/DC1)) were inserted downstream of the reporter *Fluc* gene coding region which is indicated by the black bar. The 3′-UTR is represented by the shaded bar of proportional length. Thin lines indicate the AU-rich sequence sites in *CecA1* and *Dpt*. (**B**) *Fluc* mRNA levels in S2\* cells co-transfected with Fluc reporter plasmids containing the 3′-UTR of different genes and Rluc reporter plasmid as normalization control. The qRT--PCR was performed to detect the transcript of *Fluc*. *Fluc* mRNA measured in cells transfected with the pAC-Fluc control vector was designated as 1. Values represent the mean ± SD of at least four experiments (\*\**P* \< 0.01 for each construct versus pAC-Fluc). (**C**) Luciferase activity assays of S2\* cells co-transfected with Fluc reporter plasmids containing the 3′-UTR of different genes and Rluc reporter plasmid used as normalization control. Fluc activity measured in cells transfected with the pAC-Fluc control vector is designated as 1. Values represent the mean ± SD of at least four experiments (\*\**P* \< 0.01 for each construct versus pAC-Fluc). (**D**) S2\* cells were transfected with Fluc reporter plasmids containing the 3′-UTR of *CecA1, Dpt* or no 3′-UTR inserted, and then incubated with Act.D for the time indicated. The qRT--PCR was performed to detect *Fluc* mRNA remaining at each time point, taking the *Fluc* mRNA level of each construct at the time of Act.D addition as 1. Values represent the mean ± SD (*n* = 3 independent experiments).

Compared with the control in which no 3′-UTR was inserted, inserting the 3′-UTR of *CecA1* downstream of the *Fluc* resulted in a 60% decrease in Fluc expression at both mRNA level and protein level ([Figure 2](#F2){ref-type="fig"}B and C). This indicated that *CecA1* 3′-UTR control of reporter expression mainly occurred at the mRNA level and that the *CecA1* 3′-UTR harbors a *cis* element necessary to destabilize the reporter *Fluc* mRNA. In contrast, inserting the *Dpt* 3′-UTR increased Fluc activity up to 70% but showed no significant changes at *Fluc* mRNA level, implying that a *cis* element modulating translation efficiency could exists within the *Dpt* 3′-UTR.

To further examine whether the change of *Fluc* mRNA level under the control of different AMP 3′-UTR might be due to mRNA stability, Act.D chase studies were used. As shown in [Figure 2](#F2){ref-type="fig"}D, the *Fluc* mRNA decay rate observed with *CecA1* 3′-UTR (*t*~1/2~ = 0.63 h) was faster than that seen with *Dpt* 3′-UTR (*t*~1/2~ = 1.5 h) or with no insert (*t*~1/2~ = 1.67 h)*.*

These results demonstrate that the 3′-UTR of different AMPs contributes greatly to the mRNA stability which in turn affects gene expression differentially.

The ARE in the proximal region of *CecA1* 3′-UTR is the *cis*-acting element destabilizing mRNA
-----------------------------------------------------------------------------------------------

While the AU-rich sequence in *Dpt* mRNA 3′-UTR has been characterized for its binding ability with AUBP in a previous study ([@B38]), the *CecA1* mRNA 3′-UTR contains several AU-rich sequence motifs which are scattered in the proximal region and the distal region. To clarify the role of these AU-rich sequences and to localize the *cis* element of *CecA1* 3′-UTR contributing to downregulation of gene expression, a series of fragments of *CecA1* 3′-UTR was subcloned into the 3′-end of the *Fluc* coding sequence to generate various *Fluc* reporter constructs ([Figure 3](#F3){ref-type="fig"}A). In comparison with control vector with no insert, fragments II and III both containing the AU-rich sequence in the proximal region decreased *Fluc* mRNA level significantly and resembled the inhibition effect of the full 3′-UTR (fragment I) to a great extent ([Figure 3](#F3){ref-type="fig"}B). Fragment IV, containing the AU-rich sequence in the distal region, only had a weak effect without significance in reducing *Fluc* mRNA level. Fragment V, the short proximal region excluding AU-rich sequence, had no obvious effect. Furthermore, as shown in [Figure 3](#F3){ref-type="fig"}C, the Fluc protein activity influenced by different fragments of *CecA1* 3′-UTR was consistent with its own mRNA level, demonstrating that the suppression of Fluc activity is due to reduction at the mRNA level. Overall, these results indicate that the AU-rich sequence (nt 20 to 55) in the proximal region is the AU-rich element (ARE) contributing to the decreased reporter expression and that this *CecA1* ARE in 3′-UTR can control its mRNA stability and regulate CecA1 expression. Figure 3.Effects of *CecA1* 3′-UTR fragments on reporter expression. (**A**) The sequence of *CecA1* 3′-UTR and schematic of the different fragments inserted downstream of the *Fluc*. AUUUA pentamer or AUUUUA hexamer are underlined. Each rectangle indicates an AU-rich sequence site. The AU-rich sequence with U surrounding it is indicated as a black rectangle. (**B**) *Fluc* mRNA levels in S2\* cells which were co-transfected with Fluc reporter plasmids containing the different fragments of *CecA1* 3′-UTR and Rluc reporter plasmid as normalization control. The qRT--PCR was performed to detect the expression level of *Fluc* mRNA. *Fluc* mRNA measured in cells transfected with the pAC-Fluc control vector is designated as 1. Values represent the mean ± SD of at least four experiments (\*\**P* \< 0.01 for each construct versus pAC-Fluc). (**C**) Luciferase activity assays of S2\* cells co-transfected with Fluc reporter plasmids that were inserted with different fragments of *CecA1* 3′-UTR and Rluc reporter plasmid used as normalization control. Fluc activity measured in cells transfected with the pAC-Fluc control vector is designated as 1. Values represent the mean ± SD of at least four experiments (\*\**P* \< 0.01 for each construct versus pAC-Fluc).

Identification of Tis11 as a transactor specifically regulating *CecA1* expression through ARE in the 3′-UTR
------------------------------------------------------------------------------------------------------------

AREs exert their effect on gene expression through interaction with specific ARE binding proteins (AUBPs) or with the help of microRNA (miRNA) ([@B20; @B21; @B22; @B23],[@B26],[@B39; @B40; @B41]). To identify genes that are required for *CecA1* mRNA instability control, a list of dsRNAs that target the known AUBPs, including Tis11, ELAV, RBP9 and small RNA processing factor Dicer1 were generated and used in the AUBPs knockdown by RNA interference (RNAi). These dsRNAs were co-transfected into S2\* cells with a reporter construct containing the indicated 3′-UTR and Fluc activity changes were measured. Compared with the Fluc control construct with no 3′-UTR inserted, the treatments of dsRNA specific for ELAV, RBP9 or Dicer1 had no obvious effect on Fluc activity for constructs inserted with different 3′-UTR (data not shown). However, dsRNA-treatments targeting Tis11 ([Figure 4](#F4){ref-type="fig"}A), a homologue of mammalian TTP, increased Fluc activity ∼50% for the reporter construct inserted with *CecA1* 3′-UTR ([Figure 4](#F4){ref-type="fig"}B). This effect appeared specifically mediated by the 3′-UTR of *CecA1* since knocking down Tis11 by RNAi had no obvious effect on Fluc activity changes when the constructs were inserted with *rp49* 3′-UTR, *Dpt* 3′-UTR or when no 3′-UTR was inserted. Figure 4.Knocking down Tis11 increased the activity of the reporter construct containing *CecA1* 3′-UTR. (**A**) RT--PCR was performed using specific primers to confirm the knockdown efficiency of *Tis11* in S2\* cells treated with *EGFP* or *Tis11* dsRNA. Results shown are representative of three independent experiments. (**B**) Fluc activity changes after Tis11 RNAi. S2\* cells were co-transfected with dsRNA specific for Tis11 or EGFP and a reporter construct inserted with different 3′-UTR. Luciferase activity was assayed as described. Compared in cells transfected with *EGFP* dsRNA (mock RNAi), the Fluc activity changes in Tis11 knocked down cells is shown. Values represent the mean ± SD of at least four experiments (\**P* \< 0.05; \*\**P* \< 0.01 for each construct versus both pAC-Fluc and pAC-Fluc-rp49). (**C**) S2\* cells were co-transfected with dsRNA targeting Tis11 or EGFP, human TTP expression plasmid (pAC-TTP-Flag) or control plasmid (pAC- Flag) and a reporter construct inserted with different 3′-UTR. Luciferase activity was assayed as described. Fluc activity measured in cells co-transfected with the pAC-Fluc control vector, EGFP dsRNA and pAC-Flag control expression plasmid is designated as 1. Values represent the mean ± SD of at least three experiments (\**P* \< 0.05; \*\**P* \< 0.01 for each construct versus pAC-Flag control plasmid).

Taking advantage of the deletion mutants described in [Figure 3](#F3){ref-type="fig"}A, we next investigated which portion of the *CecA1* 3′-UTR is indispensable for the destabilization by Tis11. Reducing Tis11 expression through RNAi can increase the Fluc activity ∼50% when fragment II or fragment III containing the ARE of *CecA1* 3′-UTR is inserted. Conversely, Tis11 RNAi had no significant effect when the constructs were inserted with fragment IV or V of *CecA1* 3′-UTR ([Figure 4](#F4){ref-type="fig"}B). These results show that Tis11 specifically downregulates *CecA1* gene expression through the ARE defined in the proximal region of 3′-UTR for mRNA stability control.

To determine whether mammalian TTP can regulate AMP expression, a TTP expression construct was co-transfected into S2\* cells with dsRNA targeting Tis11 such that *Tis11* was knocked down by RNAi. The expression of mammalian TTP decreased the Fluc activity significantly in S2\* cells transfected with reporter construct inserted with *CecA1* 3′-UTR and rescued the destabilizing effect on reporter mRNAs bearing AREs from mammalian (*TNF-α*) and *Drosophila* sources (*CecA1*) in S2\* cells where Tis11 were knocked down by RNAi ([Figure 4](#F4){ref-type="fig"}C). No significant destabilizing effects of TTP on reporter mRNA bearing *Dpt* 3′-UTR were observed in S2\* cells with or without Tis11 knockdown. It appears that the mammalian and *Drosophila* TTP orthologs share functional similarity regarding the specific regulation of mRNA with *CecA1* 3′-UTR but not *Dpt* 3′-UTR.

Tis11 selectively destabilizes *CecA1* mRNA and influences the transient expression kinetics
--------------------------------------------------------------------------------------------

To determine whether Tis11 can differentially reduce the endogenous AMP mRNA stability, Act.D chase studies were performed after S2\* cells were treated with dsRNA of *Tis11* or *EGFP* (negative control) for 3 days and stimulated with LPS for 2 h. As shown in [Figure 5](#F5){ref-type="fig"}A, the stability of *CecA1* mRNA was significantly increased when Tis11 was knocked down (*t*~1/2~ = 2.02 h versus *t*~1/2~ = 4.35 h). Conversely, knocking down Tis11 did not change the *Dpt* mRNA stability ([Figure 5](#F5){ref-type="fig"}B). To further validate the effectiveness of Tis11-regulated mRNA stability on the AMP mRNA expression kinetics, *CecA1* and *Dpt* mRNA expression profiles in S2\* cells, in which Tis11 was knocked down by RNAi, were detected after LPS stimulation. As shown in [Figure 5](#F5){ref-type="fig"}C, *CecA1* mRNA had a similar fold increase, but remained at a high level longer in Tis11 knocked down cells. The expression profiles of *Dpt* mRNA were similar whether Tis11 was knocked down or not ([Figure 5](#F5){ref-type="fig"}D). Figure 5.The changes in mRNA stability and gene expression profiles of AMPs after Tis11 knockdown. (**A** and **B**) S2\* cells were transfected with dsRNA specific for Tis11 or EGFP and cultured for 72 h. After exposure of cells to LPS for 2 h, Act.D was added and the preparation incubated for the indicated times. The qRT--PCR was performed to detect *CecA1* (A) and *Dpt* (B) mRNA remaining at each time point, taking the expression level at the time of Act.D addition as 1. (\*\**P*\<0.01 for EGFP dsRNA versus Tis11 dsRNA at each time point) (**C** and **D**) The qRT--PCR analysis of *CecA1* (C) or *Dpt* (D) transcripts in S2\* cells after LPS treatment under EGFP or Tis11 RNAi conditions. The fold change of *CecA1* or *Dpt* mRNA was analyzed, taking the expression level in cells transfected with EGFP dsRNA at time point of 0 h as 1. The data presented are mean ± SD of four independent experiments.

These data demonstrate that Tis11 can specifically destabilize *CecA1* mRNA and can quickly eliminate *CecA1* mRNA to manipulate the transient expression profiles of the potent AMPs when rapidly induced. Meanwhile, Tis11 has no significant effect on mRNA stability and expression profiles of moderately expressed *Dpt*.

*CecA1* mRNA forms an RNA--protein complex with Tis11 in S2\* cells
-------------------------------------------------------------------

To investigate the activity of Tis11 in specific and direct interaction with AMP mRNA in S2\* cells, an IP RT--PCR method was used to measure the amount of mRNA that coprecipitated with Tis11 protein. As shown in [Figure 6](#F6){ref-type="fig"}A, IP with anti-His antibodies dramatically enriched *CecA1* mRNA in RNP complexes from cells transfected with the construct expressing the Tis11--His fusion protein, whereas, IP in cells transfected with the construct containing the His tag control had no such effect. In contrast, IP resulted in no enrichment for other mRNAs tested including *Dpt* ([Figure 6](#F6){ref-type="fig"}A), *Def*, *Dro*, *AttB*, *Mtk* and *Drs* in S2\* cells expressing blank His tag or Tis11--His fusion protein (data not shown). Figure 6.The mRNA analyses of RNP complex IP with Tis11. S2\* cells were transfected with construct expressing Tis11-His tag or His tag and incubated for 72 h. Cells were stimulated with LPS for 3 h and then lysed to IP with anti-His tag antibody. (**A**) RNAs in the cell lysate and the IP complex were identified using RT--PCR with primers specific for *CecA1, Dpt* or *rp49*. Results shown are representative of three independent experiments. (**B**) The *CecA1* and *Dpt* mRNA in the IP complex were analysed by qRT--PCR to evaluate the relative enrichment after co-IP, taking the ratio of *rp49* mRNA level in IP samples to cell lysate as 1. Values represent the mean ± SD of three independent experiments (\*\**P* \< 0.01 for cells expressing Tis-His versus His-tag control).

The changes in *CecA1* mRNA after IP were also analyzed using qRT--PCR. After IP with anti-His antibodies in extracts from cells expressing Tis11--His fusion protein, the endogenous *CecA1* mRNA was dramatically enriched up to 14-fold as compared with *rp49* ([Figure 6](#F6){ref-type="fig"}B). In contrast, none of the other AMP mRNA tested, including *Dpt* ([Figure 6](#F6){ref-type="fig"}B), *Def*, *Dro*, *AttB*, *Mtk* and *Drs,* was enriched (data not shown).

These data demonstrate that Tis11 specifically forms an RNP complex with *CecA1* mRNA, but not with *Dpt* mRNA or any other AMP mRNA examined here in S2\* cells. These findings provide strong evidence that the specific interaction between Tis11 and *CecA1* mRNA is the essential molecular basis for the differential regulation of genes with distinct expression kinetics.

A crucial role for p38MAPK in differential regulation of AMP mRNA stability mediated by Tis11
---------------------------------------------------------------------------------------------

In order to examine the role of p38MAPK in regulating the stability of AMP mRNAs bearing AREs, we investigated the effect of p38MAPK blockade on LPS-induced posttranscriptional regulation of AMP expression. As shown in [Figure 7](#F7){ref-type="fig"}A, inhibition of p38MAPK employing a specific inhibitor, SB203580, decreased the half-life of *CecA1* mRNA significantly, whereas *Dpt* mRNA remained stable and its half-life was unchanged ([Figure 7](#F7){ref-type="fig"}B). These observations demonstrate that LPS-activated p38MAPK stabilizes mRNAs bearing the AREs in S2\* cells and that there exist differences in the extent and duration of p38MAPK inhibition between *CecA1* and *Dpt* ARE. Figure 7.Effect of p38MAPK inhibition by SB203580 on AMP mRNA stability and Tis11 expression. SB203580 or vehicle (1% DMSO) pretreated S2\* cells were incubated with 10 μg/ml LPS for 2 h. Act.D chase studies were performed to detect *CecA1* (**A**) and *Dpt* (**B**) mRNA remaining at each time point, taking the expression level at the time of Act.D addition as 1. (**C**) S2\* cells were pretreated for 0.5 h with SB203580 or vehicle. Afterward, cells were incubated with LPS for different times. The fold changes of *Tis11* mRNA were detected at each time point, taking the mRNA level of vehicle at 0 h as 1. (**D**) S2\* cells were transfected with dsRNA specific for Tis11 or EGFP and cultured for 72 h. The cells were then treated as described in (A). qRT--PCR was performed to detect *CecA1* mRNA remaining at each time point, taking the expression level at the time of Act.D addition as 1.

Through detection of Tis11 expression at mRNA level, it was indicated that LPS stimulation and/or p38MAPK blockade affect the Tis11 expression to some extent but not significantly ([Figures 7](#F7){ref-type="fig"}C). To determine the involvement of Tis11 in p38MAPK-regulated mRNA stabilization, the effects of a p38MAPK blockade on *CecA1* mRNA stability were tested in S2\* cells with Tis11 knocked down by RNA interference. As shown in [Figure 7](#F7){ref-type="fig"}D, inhibitor SB203580 treatment blocked the stabilization effect of p38MAPK and destabilized *CecA1* mRNA to a shorter half-life as compared with the DMSO treated control. However, pretreatment with RNAi knockdown of Tis11 abrogated the destabilization effect of p38MAPK inhibition by SB203580 and increased the half-life of *CecA1* mRNA to an extent comparable to the half-life upon Tis11-knockdown-induced stabilization. These results demonstrate that the stabilization effect of LPS-activated p38MAPK on *CecA1* mRNA is mediated by the RNA destabilizing protein Tis11 in *Drosophila*.

DISCUSSION
==========

*Drosophila melanogaster* can produce a large variety of AMPs, especially when a pathogen entering the body triggers the innate immune system, as shown in previous reports with Northern or micro array analyses using whole flies ([@B10],[@B12],[@B15]). Each AMP has a different antimicrobial spectrum and works together with others against microbial infection ([@B1; @B2; @B3]). On the other hand, AMPs have great influence on the resident microbiota community which is important for sustaining host health and must be maintained properly ([@B8],[@B9]). The overall effects of AMPs on pathogenic and commensal microbes are attributed to each individual AMP with its distinct antimicrobial spectrum. Undoubtedly, a controllable and dynamic antimicrobial spectrum of an integrated variety of AMPs is a complex event and is dependent upon effectively and differentially regulated expression of each AMP gene displaying distinct expression kinetics upon immune response.

In accordance with previous reports ([@B12],[@B18]), we observe that, in S2\* cells, the AMP genes were transiently expressed in a characteristic pattern in which the mRNA level increased quickly to its peak and declined afterwards upon immune response ([Figure 1](#F1){ref-type="fig"} and data not shown). Notably, *CecA1* mRNA had the highest peak level and the quickest declining rate among all the AMPs tested, including the moderately expressed *Dpt*, *Def*, *Dro*, *AttB*, *Mtk* and *Drs*. The differences in intensity and duration of gene expression indicate that the AMP genes were not regulated through the same mechanism although they shared a similar transient expression pattern. Comparing various properties of AMPs, we noted that the property distinguishing CecA1 from the other AMPs was its broad spectrum of antimicrobial activity. Previous studies have shown that CecA1 has a broad antimicrobial spectrum against Gram-positive bacteria, Gram-negative bacteria and fungi, while the antimicrobial spectra of other AMPs are quite limited. For example, the Dpt only impacts anti Gram-negative bacteria ([@B1; @B2; @B3],[@B6],[@B7]). Therefore, modulating CecA1 expression could have significant impact on the overall antimicrobial spectrum produced by all the AMPs. According to this perspective, differential regulation of genes encoding a functionally distinctive AMP, such as CecA1, is crucial for the host to orchestrate a dedicated and well balanced antimicrobial spectrum using a combination of individual AMPs.

Since gene regulation depends upon the interplay among elements that control gene expression at multiple levels including transcription, mRNA stability and translation, the differences in intensity and time of sustained high level between *CecA1* and the other AMPs may be attributed to differential regulation at multiple levels. Previous studies have shown that the differences in the κB motif at the promoters of *CecA1* and *Dpt* are not functionally equal, a fact that can partly explain the different expression profiles ([@B16; @B17; @B18]). However, neither expression profiles nor elimination of existing mRNA can be exclusively governed by transcriptional control. In fact, here we show that *CecA1* mRNA is much more unstable than *Dpt* as demonstrated using Act.D chase studies for mRNA half-life measurement. These experiments partly explain why *CecA1* is eliminated more quickly in LPS-elicited transient expression. In addition, the mRNA decay rate of each AMP was not altered whether or not S2\* cells were stimulated with LPS. This was confirmed by additional experiments with reporter constructs containing *Dpt* or *CecA1* 3′-UTR, in which the Fluc activity was regulated by the inserted 3′-UTR but not affected by LPS treatment (data not shown). These results indicate that the decay rates of *CecA1* and *Dpt* mRNAs are maintained in a constitutive manner and that the sustained pattern of mRNA stability of both AMPs is under posttranscriptional regulatory control upon LPS stimulation.

The steady decay rate of unstable mRNA results in the effective and constant elimination of mRNA. The expression of low stability genes means quick synthesis and quick mRNA decay and consumes more energy, which is also important for the host. However, compared with induction-dependent regulation, constitutive instability of mRNA is an extremely fast and effective mode for negative control of transient gene expression upon immune response. Of note, proper down-modulation of immunity is critical for protective immunity and health ([@B8],[@B9],[@B42; @B43; @B44]), and recent work has shown that hyperactivated or prolonged immune responses, including the expression of AMPs, are detrimental to the host, partly because of an altered commensal microbe population ([@B8],[@B9]). A series of negative regulators that control the intensity and duration of AMP expression, mainly at the transcriptional level, have been identified. In extracellular compartments, hemocytes phagocytose microbes and some secreted PGRPs for enzymatic degradation of peptidoglycan ([@B45],[@B46]). Inside a host cell, *Drosophila* Wnt inhibitor of Dorsal (wnt D), Defense repressor 1 (Dnr1), caspar, PIMS and rudra/pirk downregulate the Toll or IMD pathways, the major regulators of the immune response in cytoplasm of *Drosophila* ([@B43],[@B44],[@B47; @B48; @B49; @B50]). In the nucleus, AP-1 and STAT complex, activated by the JNK pathway, inhibit AMP expression through removing Relish from the promoter ([@B51]). In addition to those transcriptional down-modulations, posttranscriptional events, particularly the instability of specific mRNAs reported here, are also important determinants of the downregulation of AMP gene expression. Given that CecA1 has a more potent response and a broader spectrum of antimicrobial activity than do the other AMPs, differential instability control may play an important role in the strict regulation of its gene expression to avoid excessive effects harmful to resident microbiota and deleterious to host health. Conversely, the moderately expressed Dpt with activity against Gram-negative bacteria may have a less deleterious effect upon the host. Hence, it may not be necessary to eliminate *Dpt* mRNA quickly with an mRNA instability mechanism. The difference in mRNA stability between AMPs with different antimicrobial spectra provides an effective approach for exact control of AMP gene expression contributing to the integrated antimicrobial activity.

In the 3′-UTR of a variety of transiently expressed immediate response genes there is an ARE involved in the posttranscriptional regulation ([@B20; @B21; @B22; @B23],[@B25],[@B26]). It is highly conserved throughout evolution and can be found in species ranging from yeast and insects to mammals. Both *CecA1* and *Dpt* contain AU-rich sequences in the 3′-UTR, which likely serve as *cis*-acting elements and may be involved in posttranscriptional regulation. Our results illustrate that *CecA1* 3′-UTR, mainly through the ARE in the proximal region, can effectively accelerate reporter mRNA decay and decrease reporter mRNA level as well as reporter Fluc activity. In most cases, the magnitude of the decrease in Fluc activity was directly correlated with the corresponding decrease in *Fluc* mRNA level, suggesting that reporter gene expression is primarily dependent upon message stability. These results are consistent with the instability of the *CecA1* mRNA and indicate that *CecA1* 3′-UTR contains a functional ARE, a *cis* element destabilizing mRNA. However, inserting *Dpt* 3′-UTR downstream of the reporter has no obvious effect on reporter mRNA stability change, but increases the reporter Fluc activity significantly. This implies that a *cis* element increasing the translation efficiency may exist within the *Dpt* 3′-UTR or that additional *trans* factors may be involved in the modulation of translational efficiency, all of which possibilities should be further investigated. The different roles of *CecA1* and *Dpt* 3′-UTR on mRNA stability and protein expression indicate that 3′-UTR plays important roles in versatile and differential regulation of AMP gene expression.

AREs function as posttranscriptional regulatory elements through interactions with specific binding proteins or microRNA ([@B20],[@B21],[@B26],[@B39]). Using RNA interference to screen known RNA binding proteins, we identified *Drosophila* Tis11, a homolog of mammalian TTP, as a *trans*-factor controlling *CecA1* mRNA stability. Characterized by a tandem CCCH zinc-finger (TZF) domain with highly conserved sequences and spacing, TTP can bind to ARE of unstable mRNAs through TZF domains and can induce mRNA deadenylation, promote degradation of the mRNA body by the exosome complex, or assist the RISC--miRNA complex with targeting mRNA for rapid degradation ([@B39],[@B52; @B53; @B54]). *Drosophila* Tis11 also contains two CCCH zinc-finger domains that are necessary for mammalian TTP to interact with AU-rich elements, destabilizing the mRNA of reporter construct with *CecA1* 3′-UTR mainly through interaction with the ARE in the proximal region of *CecA1* 3′-UTR. Moreover, we demonstrated, using an IP RT--PCR method, that *CecA1* mRNA and Tis11 were co-precipitated in an RNA--protein complex. It is observed that the ARE in the proximal region of *CecA1* 3′-UTR contains a UUAUUUAUU sequence, characterized previously as a preferred binding site for mammalian TTP, and indicates that *Drosophila* Tis11 has a similar binding characteristic to that of mammalian TTP. Although *Dpt* mRNA 3′-UTR contains the AU-rich sequence, UAUUUUAUU, which also has an optimal affinity to mammalian TTP ([@B32],[@B33]), it can increase Fluc reporter activity but cannot be pulled down with *Drosophila* Tis11 protein using co-IP. This is consistent with the fact that knocking down Tis11 or over-expressing TTP has little effect on *Dpt* mRNA stability and expression profiles. Perhaps *Dpt* does not have the same recognition and binding property as mammalian ARE, or additional factors involved in influencing the affinity and specificity of the RNA--protein complex forming with Tis11.

Data from the work of Jing *et al.* ([@B39]) have shown that the *Drosophila* Tis11 can destabilize reporter mRNA inserted with *TNF-α* 3′-UTR and the involvement of microRNA is indicated. However, reducing the expression of Dicer1, playing key roles in processing small RNAs in miRNA systems, has no effect on expression of reporters inserted with *CecA1* 3′-UTR (data not shown) indicating that a RISC--miRNA complex does not participate in *CecA1* mRNA stability control. While preparing this article, we noticed that recent work reported by Aurélien *et al.* ([@B55]) demonstrated that Tis11 downregulates *CecA1* mRNA stability through acceleration of mRNA deadenylation similar to that of TTP in mammals.

AREs can exert mRNA instability effects but can also confer stabilization of mRNA through the p38MAPK pathway. p38MAPK has been shown to regulate both the translation and the stability of inflammatory mRNAs bearing AREs, including *TNF-α*, *COX-2*, *GMCSF* and *VEGF* ([@B30],[@B31]), in mammalian cells. Previous study has shown that p38MAPK regulates levels of AMP transcripts in *Drosophila* ([@B56]). We have demonstrated in this study that p38MAPK plays a crucial role in regulating the stability of AMP mRNAs bearing the AREs in their 3′-UTR upon LPS activation of p38MAPK in S2\* cells. The p38MAPK inhibitor SB203580 can specifically and effectively decrease the half-life of *CecA1* mRNA. Of note, our results in this report indicate that the decay rate of *CecA1* mRNA remains unaffected upon LPS stimulation as compared to the basal level. Thus, it is suggested that p38MAPK contributes its stabilizing role to a regulatory mechanism coordinating stabilizing and destabilizing regulation to ensure a steady level of degradation rate of the transcript upon LPS stimulation.

The important component of the mechanism of p38MAPK-regulated mRNA stability is a protein that forms the link between the p38MAPK pathway and ARE-containing mRNA. In mammals, the TTP has been suggested to be the protein factor but is not firmly recognized because of evidence for and against its involvement in p38MAPK-mediated stabilization ([@B30],[@B57]). Using RNAi knockdown of Tis11, the *Drosophila* homolog of TTP, we observed that the destabilizing effect of p38MAPK blockade by SB203580 was abrogated. This provides evidence that Tis11 is involved in the regulation of AMP mRNA stability by p38MAPK in S2\* cells. Further detection of Tis11 expression at mRNA level indicates that LPS stimulation and/or p38MAPK blockade affects Tis11 expression to some extent but not significantly. It remains unclear as to how p38MAPK regulates AMP mRNA stability mediated by Tis11-AREs interaction. In the future, it would be of interest to determine whether protein phosphorylation of Tis11 affects the regulation of mRNA stability and whether p38MAPK regulates the phosphorylation status of Tis11.

ARE is a highly conserved posttranscriptional regulatory element throughout evolution and can be found in species from yeasts and insects to mammals ([@B24; @B25; @B26]). Our previous study ([@B38]) has shown the existence of ARE in 3′-UTR of AMP mRNA. We further demonstrate in this report that AREs in 3′-UTR of AMP mRNA are functional elements in the posttranscriptional regulation of AMP gene expression, a mechanism that is extremely important in the innate immunity of insects. Likewise, AREs have been known to play critical roles in the posttranscriptional regulation of gene expression in response to immune stimuli in mammals. It was emphasized and explicated in a recent study that ARE-regulated mRNA stability exerts a strong influence on gene expression, in some cases overriding that of transcriptional control elements, and controlling the expression kinetics of genes encoding inflammatory molecules ([@B58]). In addition, the *trans*-acting protein factor mediating ARE destabilization is *Drosophila* Tis11, the ortholog of mammalian TTP. Although the AREs of AMP mRNA exert no destabilizing effect in mammalian cells (data not shown), our results support a previous report ([@B39]) that the *Drosophila* Tis11 can destabilize reporter mRNA inserted with *TNF-α* 3′-UTR. Besides, expression of TTP in S2\* cells with Tis11 knockdown can rescue the destabilizing effect on reporter mRNAs bearing AREs. This evidence indicates that the ARE destabilizing *trans*-acting factors are evolutionarily conserved between invertebrate and mammalian immune systems. Furthermore, we reveal that p38MAPK regulates the stability of the AMP mRNA containing ARE in the 3′-UTR as mediated by Tis11, demonstrating a mechanism strikingly similar to that of p38MAPK-regulated mRNA stabilization in mammalian cells through inhibition of TTP-mediated destabilization in most case ([@B31]). Obviously, AREs and relevant regulatory mechanisms have become more complex later in evolution, but the main framework is evolutionarily conserved between invertebrates and mammals and reflects many important mechanisms present in ancestral forms. In particular, evolutionary conservation is manifested in posttranscriptional regulation of gene expression in both fly and mammalian immunity.

Taken together, our results demonstrate that AMPs possessing different antimicrobial spectra exhibit significant differences in gene expression profiles evidently attributed to differential regulation at the posttranscriptional level. While *Dpt* 3′-UTR has no destabilizing effect, *CecA1* 3′-UTR is both necessary and sufficient to confer instability through the ARE--Tis11 interaction within the RNP complex. It is further demonstrated that the destabilization is counteracted by p38MAPK which plays a crucial role in stabilizing ARE-bearing mRNAs by inhibiting Tis11-mediated degradation, a posttranscriptional mechanism that is evolutionarily conserved in both fly and mammalian immunity.
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